LOTUSEYE

Lotus Eye Hospital and Institute Share Price

₹69.89 +1.64 (2.4%)

05 Nov, 2024 17:29

SIP TrendupStart SIP in LOTUSEYE

Start SIP

Performance

  • Low
  • ₹67
  • High
  • ₹70
  • 52 Week Low
  • ₹49
  • 52 Week High
  • ₹111
  • Open Price₹68
  • Previous Close₹68
  • Volume5,606

Investment Returns

  • Over 1 Month -9.81%
  • Over 3 Month + 5.97%
  • Over 6 Month + 13.18%
  • Over 1 Year -19.53%
SIP Lightning

Smart Investing Starts Here Start SIP with Lotus Eye Hospital and Institute for Steady Growth!

Lotus Eye Hospital and Institute Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 67.5
  • PEG Ratio
  • -1.4
  • Market Cap Cr
  • 145
  • P/B Ratio
  • 2.4
  • Average True Range
  • 4.15
  • EPS
  • 1.4
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.86
  • RSI
  • 42.16
  • MFI
  • 37.33

Lotus Eye Hospital and Institute Financial

IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations12.8910.8812.0312.7312.57
Total Income From Operations12.8910.8812.0312.7312.57
P/L Before Interest, Excpt. Items & Tax0.910.040.941.191.94
P/L Before Exceptional Items & Tax0.860.000.911.181.92
P/L After Tax from Ordinary Activities0.620.020.660.851.38
Net Profit/Loss For the Period0.620.020.660.851.38
IndicatorMar 24Mar 23
Revenue From Operations [Gross]47.2445.98
Revenue From Operations [Net]47.2445.98
Total Operating Revenues48.2147.04
Total Revenue49.5148.19
Total Expenses45.5042.54
Profit/Loss Before Tax4.015.65
Profit/Loss For The Period2.914.08
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity5.684.39
Net Cash Used In Investing Activity-4.63-2.19
Net Cash Used in Finance Activity-3.40-1.71
Net Inc/Dec In Cash And Equivalent-2.350.49
Cash And Equivalent End Of Year6.939.28
IndicatorMar 24Mar 23
Total Share Capital20.8020.80
Total Non-Current Liabilities0.990.42
Total Current Liabilities6.235.19
Total Capital And Liabilities66.6363.19
Total Non-Current Assets52.6148.48
Total Current Assets14.0214.71
Total Assets66.6363.19
Indicator20242023
EBIT Margin (%)8.5112.22
Return On Capital Employed (%)6.799.91
Return On Equity (%)4.907.08
Long Term Debt To Equity (%)0.000.00
Book Value/Share (INR)28.5727.69
Indicator20242023
EBIT Margin (%)8.5112.22
Return On Capital Employed (%)6.799.91
Return On Equity (%)4.907.08
Long Term Debt To Equity (%)0.000.00
Book Value/Share (INR)28.5727.69

Lotus Eye Hospital and Institute Technicals

EMA & SMA

Current Price
₹69.89
+ 1.64 (2.4%)
pointer
  • stock-down_img
  • Bullish Moving Average 7
  • stock-up_img
  • Bearish Moving Average 9
  • 20 Day
  • ₹70.50
  • 50 Day
  • ₹71.94
  • 100 Day
  • ₹70.91
  • 200 Day
  • ₹70.91

Resistance and Support

69.66 Pivot Speed
  • R3 78.06
  • R2 75.73
  • R1 71.99
  • S1 65.92
  • S2 63.59
  • S3 59.85

Is Lotus Eye Hospital and Institute Worth Buying?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Lotus Eye Hospital And Institute has an operating revenue of Rs. 48.53 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 8% is okay, ROE of 4% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -17% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 45 which is a POOR score indicating inconsistency in earnings, a RS Rating of 30 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Lotus Eye Hospital and Institute Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-12 Quarterly Results
2023-08-14 Quarterly Results
2023-05-24 Audited Results & Dividend
2023-02-13 Quarterly Results
2022-11-14 Audited Results
Date Purpose Remarks
2022-09-10 FINAL Rs.0.50 per share(5%)Final Dividend

Lotus Eye Hospital and Institute F&O

Lotus Eye Hospital and Institute Shareholding Pattern

40.03%
0%
42.84%
17.13%
  • NSE Symbol
  • LOTUSEYE
  • BSE Symbol
  • 532998
  • Managing Director
  • Ms. Sangeetha Sundaramoorthy
  • ISIN
  • INE947I01017

Lotus Eye Hospital and Institute FAQs

Lotus Eye Hospital and Institute share price is ₹69 As on 05 November, 2024 | 17:15

The Market Cap of Lotus Eye Hospital and Institute is ₹145.3 Cr As on 05 November, 2024 | 17:15

The P/E ratio of Lotus Eye Hospital and Institute is 67.5 As on 05 November, 2024 | 17:15

The PB ratio of Lotus Eye Hospital and Institute is 2.4 As on 05 November, 2024 | 17:15

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form